These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35366763)

  • 1. Selective Delivery of Clinically Approved Tubulin Binding Agents through Covalent Conjugation to an Active Targeting Moiety.
    Collyer SE; Stack GD; Walsh JJ
    Curr Med Chem; 2022 Aug; 29(31):5179-5211. PubMed ID: 35366763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Water-soluble polymers for targeted drug delivery to human squamous carcinoma of head and neck.
    Nan A; Ghandehari H; Hebert C; Siavash H; Nikitakis N; Reynolds M; Sauk JJ
    J Drug Target; 2005 Apr; 13(3):189-97. PubMed ID: 16036307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting HER2-positive cancer with dolastatin 15 derivatives conjugated to trastuzumab, novel antibody-drug conjugates.
    Gianolio DA; Rouleau C; Bauta WE; Lovett D; Cantrell WR; Recio A; Wolstenholme-Hogg P; Busch M; Pan P; Stefano JE; Kramer HM; Goebel J; Krumbholz RD; Roth S; Schmid SM; Teicher BA
    Cancer Chemother Pharmacol; 2012 Sep; 70(3):439-49. PubMed ID: 22821053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimising the delivery of tubulin targeting agents through antibody conjugation.
    Stack GD; Walsh JJ
    Pharm Res; 2012 Nov; 29(11):2972-84. PubMed ID: 22777294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Tubulin-colchicine Site for Cancer Therapy: Inhibitors, Antibody- Drug Conjugates and Degradation Agents.
    Duan Y; Liu W; Tian L; Mao Y; Song C
    Curr Top Med Chem; 2019; 19(15):1289-1304. PubMed ID: 31210108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How do microtubule-targeted drugs work? An overview.
    Jordan MA; Kamath K
    Curr Cancer Drug Targets; 2007 Dec; 7(8):730-42. PubMed ID: 18220533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of transferrin receptors in oncology: the development of functional nano-based drug delivery systems.
    Tortorella S; Karagiannis TC
    Curr Drug Deliv; 2014; 11(4):427-43. PubMed ID: 24387131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural products as antimitotic agents.
    Dall'Acqua S
    Curr Top Med Chem; 2014; 14(20):2272-85. PubMed ID: 25434355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells.
    Huang YF; Shangguan D; Liu H; Phillips JA; Zhang X; Chen Y; Tan W
    Chembiochem; 2009 Mar; 10(5):862-8. PubMed ID: 19253922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tubulin-based antimitotic mechanism of E7974, a novel analogue of the marine sponge natural product hemiasterlin.
    Kuznetsov G; TenDyke K; Towle MJ; Cheng H; Liu J; Marsh JP; Schiller SE; Spyvee MR; Yang H; Seletsky BM; Shaffer CJ; Marceau V; Yao Y; Suh EM; Campagna S; Fang FG; Kowalczyk JJ; Littlefield BA
    Mol Cancer Ther; 2009 Oct; 8(10):2852-60. PubMed ID: 19825803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic Anticancer Effect of Peptide-Docetaxel Nanoassembly Targeted to Tubulin: Toward Development of Dual Warhead Containing Nanomedicine.
    Mohapatra S; Saha A; Mondal P; Jana B; Ghosh S; Biswas A; Ghosh S
    Adv Healthc Mater; 2017 Jan; 6(2):. PubMed ID: 27782376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring the Disruptive Effects of Tubulin-Binding Agents on Cellular Microtubules.
    Kumari A; Panda D
    Methods Mol Biol; 2022; 2430():431-448. PubMed ID: 35476348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target driven preclinical screening for new antimitotic chemotherapy agents.
    Novío S; Freire-Garabal M; Núñez MJ
    Curr Top Med Chem; 2014; 14(20):2263-71. PubMed ID: 25434356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective Inhibition of Spindle Microtubules by a Tubulin-Binding Quinazoline Derivative.
    Sawada JI; Ishii H; Matsuno K; Sato M; Suzuki Y; Asai A
    Mol Pharmacol; 2019 Nov; 96(5):609-618. PubMed ID: 31471455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting urokinase and the transferrin receptor with novel, anti-mitotic N-alkylisatin cytotoxin conjugates causes selective cancer cell death and reduces tumor growth.
    Vine KL; Indira Chandran V; Locke JM; Matesic L; Lee J; Skropeta D; Bremner JB; Ranson M
    Curr Cancer Drug Targets; 2012 Jan; 12(1):64-73. PubMed ID: 22111834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-mediated drug delivery.
    Arslan FB; Ozturk Atar K; Calis S
    Int J Pharm; 2021 Mar; 596():120268. PubMed ID: 33486037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico design of tubulin-targeted antimitotic peptides.
    Pieraccini S; Saladino G; Cappelletti G; Cartelli D; Francescato P; Speranza G; Manitto P; Sironi M
    Nat Chem; 2009 Nov; 1(8):642-8. PubMed ID: 21378956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of chalcone-amidobenzothiazole conjugates as antimitotic and apoptotic inducing agents.
    Kamal A; Mallareddy A; Suresh P; Shaik TB; Lakshma Nayak V; Kishor C; Shetti RV; Sankara Rao N; Tamboli JR; Ramakrishna S; Addlagatta A
    Bioorg Med Chem; 2012 Jun; 20(11):3480-92. PubMed ID: 22543234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transferrin receptor-mediated endocytosis: a useful target for cancer therapy.
    Tortorella S; Karagiannis TC
    J Membr Biol; 2014 Apr; 247(4):291-307. PubMed ID: 24573305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.